TABLE 1.
Presentation routes of patients diagnosed with new or newly recurrent HNC by year
| 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|
| New HNC | ||||
| Emergency presentation: n (%) | 8 (4.3) | 6 (3.2) | 8 (4.0) | 21 (12.3) a |
| Other routes: n (%) | 177 (95.7) | 184 (96.8) | 190 (96.0) | 150 (87.7) |
| Total: n (%) | 185 | 190 | 198 | 171 |
| Newly recurrent HNC | ||||
| Emergency presentation: n (%) | 5 (7.6) | 3 (7.5) | 3 (9.1) | 8 (19.5) b |
| Other routes: n (%) | 61 (92.4) | 37 (92.5) | 30 (90.9) | 33 (80.5) |
| Total: n (%) | 66 | 40 | 33 | 41 |
| New/newly recurrent HNC combined | ||||
| Emergency presentation: n (%) | 13 (5.2) | 9 (3.9) | 11 (4.8) | 29 (13.7) c |
| Other routes: n (%) | 238 (94.8) | 221 (96.1) | 220 (95.2) | 183 (86.3) |
| Total: n (%) | 251 | 230 | 231 | 212 |
Each year represents the six‐month period of June‐November inclusive.
a
Significant increase in the proportion of patients presenting in an emergency context with a new HNC diagnosis (P < .001).
b
Significant increase in the proportion of patients presenting in an emergency context with a newly recurrent HNC diagnosis (P = .018).
c
Significant increase in the proportion of patients presenting in an emergency context with a new or newly recurrent HNC diagnosis combined (P < .001).